Inactive Instrument

Highlights Acacia Pharma Group plc

Equities

ACPH

GB00BYWF9Y76

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Eagle Pharmaceuticals Completes Acacia Pharma Acquisition	22-06-09	MT
Acacia Pharma's Acquisition by Eagle Pharmaceuticals Closes; Shares Delist	22-06-09	MT
Acacia Pharma's Acquisition by Eagle Pharmaceuticals Nears Completion	22-06-07	MT
Eagle Pharmaceuticals, Inc. completed the acquisition of Acacia Pharma Group plc from a group of shareholders.	22-06-05	CI
Acacia Pharma Group plc Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Eagle Pharmaceuticals to Acquire Acacia Pharma	22-03-28	MT
Acacia Pharma Accepts $104 Million Takeover Bid from US-Based Eagle Pharmaceuticals	22-03-28	MT
Eagle Pharmaceuticals, Inc. entered into an agreement to acquire Acacia Pharma Group plc from a group of shareholders for €89.8 million.	22-03-27	CI
Acacia Pharma Announces Successful Completion of Barhemsys® Post-Approval Requirement Study in Patients with Severe Renal Impairment	21-12-13	CI
Acacia Pharma Group plc Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-30	CI
Acacia Pharma : Files Marketing Authorization Application For Barhemsys In Europe	21-09-29	MT
Acacia Pharma Announces Submission and Validation of Marketing Authorization Application for BARHEMSYS® (amisulpride injection) in Major European Markets	21-09-29	CI
Acacia Pharma Announces Initiation of Pivotal Study of Byfavo® in Pediatric Procedural Sedation	21-09-16	CI
Acacia Pharma Group plc Announces Its Significant Continued Progress Withformulary Uptake of Barhemsys® and Byfavo™ in the Us	21-07-01	CI
Acacia Pharma Group plc Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-28	CI
Acacia Pharma : Changes EU Home Member State to Belgium	21-02-18	MT
Acacia Pharma Launches Byfavo (Remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less	21-01-28	CI
Cosmo Pharmaceuticals N : to Receive $6 Million Milestone Payment from Acacia on First US Sale of Byfavo	20-12-15	MT
Acacia Pharma Group plc Announces BYFAVO™ for Procedural Sedation	20-10-06	CI
Acacia Pharma Group plc Launches BARHEMSYS	20-08-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Acacia Pharma Group plc

Equities

ACPH

GB00BYWF9Y76

Highlights

Filters